Immunotherapy of Equine Sarcoids-From Early Approaches to Innovative Vaccines.

Vaccines (Basel)

Research Group Oncology (RGO), Division of Equine Surgery, Department for Companion Animals and Horses, University of Veterinary Medicine, 1210 Vienna, Austria.

Published: March 2023

Horses and other equid species are frequently affected by bovine papillomavirus type 1 and/or 2 (BPV1, BPV2)-induced skin tumors termed sarcoids. Although sarcoids do not metastasize, they constitute a serious health problem due to their BPV1/2-mediated resistance to treatment and propensity to recrudesce in a more severe, multiple form following accidental or iatrogenic trauma. This review provides an overview on BPV1/2 infection and associated immune escape in the equid host and presents early and recent immunotherapeutic approaches in sarcoid management.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10145708PMC
http://dx.doi.org/10.3390/vaccines11040769DOI Listing

Publication Analysis

Top Keywords

immunotherapy equine
4
equine sarcoids-from
4
sarcoids-from early
4
early approaches
4
approaches innovative
4
innovative vaccines
4
vaccines horses
4
horses equid
4
equid species
4
species frequently
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!